igf-1 lr3 usage LONG® R³ IGF-I LR3-IGF-I (Receptor Grade), Human -
Description
Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results
(480 g ) with the high-brake setting for 8 min
The therapeutic forms include an ointment and L-lysine hydrochloride orally in 13 g/day dosages
10.1093/nar/gky1079 194 PaggiJ
J Nanobiotechnology (2004) 6:16
